137 related articles for article (PubMed ID: 30623362)
21. Wnt Signalling-Targeted Therapy in the CMS2 Tumour Subtype: A New Paradigm in CRC Treatment?
Albuquerque C; Pebre Pereira L
Adv Exp Med Biol; 2018; 1110():75-100. PubMed ID: 30623367
[TBL] [Abstract][Full Text] [Related]
22. Prognosis of stage III colorectal carcinomas with FOLFOX adjuvant chemotherapy can be predicted by molecular subtype.
Kwon Y; Park M; Jang M; Yun S; Kim WK; Kim S; Paik S; Lee HJ; Hong S; Kim TI; Min B; Kim H
Oncotarget; 2017 Jun; 8(24):39367-39381. PubMed ID: 28455965
[TBL] [Abstract][Full Text] [Related]
23. Clinical and Molecular Comparative Study of Colorectal Cancer Based on Age-of-onset and Tumor Location: Two Main Criteria for Subclassifying Colorectal Cancer.
Álvaro E; Cano JM; García JL; Brandáriz L; Olmedillas-López S; Arriba M; Rueda D; Rodríguez Y; Cañete Á; Arribas J; Inglada-Pérez L; Pérez J; Gómez C; García-Arranz M; García-Olmo D; Goel A; Urioste M; González-Sarmiento R; Perea J
Int J Mol Sci; 2019 Feb; 20(4):. PubMed ID: 30813366
[TBL] [Abstract][Full Text] [Related]
24. Colorectal serrated pathway cancers and precursors.
O'Brien MJ; Zhao Q; Yang S
Histopathology; 2015 Jan; 66(1):49-65. PubMed ID: 25263173
[TBL] [Abstract][Full Text] [Related]
25. Colorectal neoplasia pathways: state of the art.
IJspeert JE; Medema JP; Dekker E
Gastrointest Endosc Clin N Am; 2015 Apr; 25(2):169-82. PubMed ID: 25839680
[TBL] [Abstract][Full Text] [Related]
26. Molecular biomarkers and classification models in the evaluation of the prognosis of colorectal cancer.
Sideris M; Papagrigoriadis S
Anticancer Res; 2014 May; 34(5):2061-8. PubMed ID: 24778007
[TBL] [Abstract][Full Text] [Related]
27. Cell Line Models of Molecular Subtypes of Colorectal Cancer.
Mooi JK; Luk IY; Mariadason JM
Methods Mol Biol; 2018; 1765():3-26. PubMed ID: 29589298
[TBL] [Abstract][Full Text] [Related]
28. Selective analysis of cancer-cell intrinsic transcriptional traits defines novel clinically relevant subtypes of colorectal cancer.
Isella C; Brundu F; Bellomo SE; Galimi F; Zanella E; Porporato R; Petti C; Fiori A; Orzan F; Senetta R; Boccaccio C; Ficarra E; Marchionni L; Trusolino L; Medico E; Bertotti A
Nat Commun; 2017 May; 8():15107. PubMed ID: 28561063
[TBL] [Abstract][Full Text] [Related]
29. Molecular therapy of colorectal cancer: progress and future directions.
Weng W; Feng J; Qin H; Ma Y
Int J Cancer; 2015 Feb; 136(3):493-502. PubMed ID: 24420815
[TBL] [Abstract][Full Text] [Related]
30. HNPCC and sporadic MSI-H colorectal cancer: a review of the morphological similarities and differences.
Jass JR
Fam Cancer; 2004; 3(2):93-100. PubMed ID: 15340259
[TBL] [Abstract][Full Text] [Related]
31. Combination of microsatellite instability and BRAF mutation status for subtyping colorectal cancer.
Seppälä TT; Böhm JP; Friman M; Lahtinen L; Väyrynen VM; Liipo TK; Ristimäki AP; Kairaluoma MV; Kellokumpu IH; Kuopio TH; Mecklin JP
Br J Cancer; 2015 Jun; 112(12):1966-75. PubMed ID: 25973534
[TBL] [Abstract][Full Text] [Related]
32. Colorectal cancer subtypes: Translation to routine clinical pathology.
Roseweir AK; McMillan DC; Horgan PG; Edwards J
Cancer Treat Rev; 2017 Jun; 57():1-7. PubMed ID: 28505475
[TBL] [Abstract][Full Text] [Related]
33. Clinicopathological characteristics of serrated polyps as precursors to colorectal cancer: Current status and management.
Okamoto K; Kitamura S; Kimura T; Nakagawa T; Sogabe M; Miyamoto H; Muguruma N; Takayama T
J Gastroenterol Hepatol; 2017 Feb; 32(2):358-367. PubMed ID: 27376251
[TBL] [Abstract][Full Text] [Related]
34. Evolving molecular classification by genomic and proteomic biomarkers in colorectal cancer: potential implications for the surgical oncologist.
Søreide K; Nedrebø BS; Knapp JC; Glomsaker TB; Søreide JA; Kørner H
Surg Oncol; 2009 Mar; 18(1):31-50. PubMed ID: 18672360
[TBL] [Abstract][Full Text] [Related]
35. Molecular Testing for the Treatment of Advanced Colorectal Cancer: An Overview.
Lin PS; Semrad TJ
Methods Mol Biol; 2018; 1765():281-297. PubMed ID: 29589315
[TBL] [Abstract][Full Text] [Related]
36. Annexin A10 expression correlates with serrated pathway features in colorectal carcinoma with microsatellite instability.
Kim JH; Rhee YY; Kim KJ; Cho NY; Lee HS; Kang GH
APMIS; 2014 Dec; 122(12):1187-95. PubMed ID: 24909058
[TBL] [Abstract][Full Text] [Related]
37. [Molecular pathology of colorectal cancer].
Neumann JH; Jung A; Kirchner T
Pathologe; 2015 Mar; 36(2):137-44. PubMed ID: 25777075
[TBL] [Abstract][Full Text] [Related]
38. Establishment and characterization of cell lines from chromosomal instable colorectal cancer.
Maletzki C; Gock M; Randow M; Klar E; Huehns M; Prall F; Linnebacher M
World J Gastroenterol; 2015 Jan; 21(1):164-76. PubMed ID: 25574089
[TBL] [Abstract][Full Text] [Related]
39. Distinct clinical outcomes of two CIMP-positive colorectal cancer subtypes based on a revised CIMP classification system.
Bae JM; Kim JH; Kwak Y; Lee DW; Cha Y; Wen X; Lee TH; Cho NY; Jeong SY; Park KJ; Han SW; Lee HS; Kim TY; Kang GH
Br J Cancer; 2017 Apr; 116(8):1012-1020. PubMed ID: 28278514
[TBL] [Abstract][Full Text] [Related]
40. Molecular pathology of colorectal carcinoma. A systematic review centred on the new role of the pathologist.
Remo A; Pancione M; Zanella C; Vendraminelli R
Pathologica; 2012 Dec; 104(6):432-41. PubMed ID: 23547429
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
